Blood WBC : 1.5 X 10 9 /l HB : 10.3g/dl Platelets : 52 X 10 9 /l Bone marrow : Aspirate and immunophenotype study: 69.8% lymphoid cells, CD19+, CD5++, CD11c+, CD23++, cyIgM+, cylambda+.
Cyto-Pathology Classification
Immunophenotype Small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) Rearranged Ig Tcr Not done Pathology Lymph node biopsy showed SLL/CLL, CD20, CD23, CD5, CD43 and BCL2 positive; CD10 and Cyclin D1 negative and Ki-67 positive in 25% of neoplastic cells. Electron microscopy Not done Diagnosis Chronic lymphocytic leukaemia/Small lymphocytic lymphoma (CLL/SLL) with high Ki-67 index.
Survival
Date of diagnosis: 03-2010 Treatment: Bendamustine +Rituximab (2 cycles).
Chronic lymphocytic leukaemia/Small lymphocytic lymphoma (CLL/SLL)
Rodrigues Pereira Velloso ED, et al. associated with translocation t(1; 6)(p35; p25) 
Other Molecular Studies

Technics: not done
Partial karyotypes, G-bands, showing the t(1;6)(p35;q21), del(4)(q21), and add(17)(p13).
Fish interphase study using probes D17Z1 (green) and p53 (orange) showing 2 green signals and 1 orange signal, confirming p53 deletion.
Chronic lymphocytic leukaemia/Small lymphocytic lymphoma (CLL/SLL)
469
Ki-67 immunostaining in lymph node at time of t(1;6) detection.
Comments
Until now, 16 patients with CLL and t(1;6)(p35;p25) were described. 8 of these patients were described by Michaux et al. in 2005, showing that this rearrangement was associated with bad prognosis: unmutated B-CLL and evolution to diffuse large B-cell Lymphoma (DLBCL). Our group also described in 2007 a case of atypical CLL with evolution to aggressive B-cell Lymphoma. In the case reported herein, clinical and pathological evolution was associated with the detection of t(1;6) as part of complex karyotype including deletion of p53. Although no transformation to DLBCL was seen, increase in proliferation rate in lymph node biopsy (Ki-67 increase from less than10 to 25%) was detected, associated with bad prognosis and short survival.
